Pages that link to "Item:Q3201547"
From MaRDI portal
The following pages link to Designs for Group Sequential Phase II Clinical Trials (Q3201547):
Displaying 12 items.
- On the maximum total sample size of a group sequential test about bivariate binomial propor\-tions (Q544640) (← links)
- Bayesian phase II adaptive randomization by jointly modeling time-to-event efficacy and binary toxicity (Q746098) (← links)
- On Bayesian estimators in multistage binomial designs (Q951050) (← links)
- A review of phase 2-3 clinical trial designs (Q1029784) (← links)
- On the maximum total sample size of a group sequential test about binomial proportions. (Q1423275) (← links)
- Methodology and application of adaptive and sequential approaches in contemporary clinical trials (Q1929694) (← links)
- Two-Stage Designs with Additional Futility Tests for Phase II Clinical Trials with Heterogeneous Patient Populations (Q3094217) (← links)
- MULTINOMIAL PHASE II CANCER TRIALS INCORPORATING RESPONSE AND EARLY PROGRESSION (Q4512728) (← links)
- Improving the Flexibility and Efficiency of Phase II Designs for Oncology Trials (Q4649069) (← links)
- Assurance test and its equivalent truncated sequential test (Q5077207) (← links)
- Nearly optimal truncated group sequential test on binomial proportions (Q5085028) (← links)
- A class of confidence intervals for sequential phase II clinical trials with binary outcome (Q5124775) (← links)
